Literature DB >> 32171390

Real estimates of mortality following COVID-19 infection.

David Baud1, Xiaolong Qi2, Karin Nielsen-Saines3, Didier Musso4, Léo Pomar5, Guillaume Favre5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32171390      PMCID: PMC7118515          DOI: 10.1016/S1473-3099(20)30195-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
As of March 1, 2020, 79 968 patients in China and 7169 outside of China had tested positive for coronavirus disease 2019 (COVID-19). Among Chinese patients, 2873 deaths had occurred, equivalent to a mortality rate of 3·6% (95% CI 3·5–3·7), while 104 deaths from COVID-19 had been reported outside of China (1·5% [1·2–1·7]). However, these mortality rate estimates are based on the number of deaths relative to the number of confirmed cases of infection, which is not representative of the actual death rate; patients who die on any given day were infected much earlier, and thus the denominator of the mortality rate should be the total number of patients infected at the same time as those who died. Notably, the full denominator remains unknown because asymptomatic cases or patients with very mild symptoms might not be tested and will not be identified. Such cases therefore cannot be included in the estimation of actual mortality rates, since actual estimates pertain to clinically apparent COVID-19 cases. The maximum incubation period is assumed to be up to 14 days, whereas the median time from onset of symptoms to intensive care unit (ICU) admission is around 10 days.3, 4 Recently, WHO reported that the time between symptom onset and death ranged from about 2 weeks to 8 weeks. We re-estimated mortality rates by dividing the number of deaths on a given day by the number of patients with confirmed COVID-19 infection 14 days before. On this basis, using WHO data on the cumulative number of deaths to March 1, 2020, mortality rates would be 5·6% (95% CI 5·4–5·8) for China and 15·2% (12·5–17·9) outside of China. Global mortality rates over time using a 14-day delay estimate are shown in the figure , with a curve that levels off to a rate of 5·7% (5·5–5·9), converging with the current WHO estimates. Estimates will increase if a longer delay between onset of illness and death is considered. A recent time-delay adjusted estimation indicates that mortality rate of COVID-19 could be as high as 20% in Wuhan, the epicentre of the outbreak. These findings show that the current figures might underestimate the potential threat of COVID-19 in symptomatic patients.
Figure

Global COVID-19 mortality rates (Feb 11 to March 1, 2020)

Current WHO mortality estimates (total deaths divided by total confirmed cases), and mortality rates calculated by dividing the total number of deaths by the total number of confirmed cases 14 days previously.

Global COVID-19 mortality rates (Feb 11 to March 1, 2020) Current WHO mortality estimates (total deaths divided by total confirmed cases), and mortality rates calculated by dividing the total number of deaths by the total number of confirmed cases 14 days previously.
  3 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

3.  Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.

Authors:  Jantien A Backer; Don Klinkenberg; Jacco Wallinga
Journal:  Euro Surveill       Date:  2020-02
  3 in total
  370 in total

1.  COVID-19: Urgent Reconsideration of Lung Edema as a Preventable Outcome: Inhibition of TRPV4 As a Promising and Feasible Approach.

Authors:  Wolfgang Kuebler; Sven-Eric Jordt; Wolfgang Liedtke
Journal:  SSRN       Date:  2020-03-23

2.  Overview of the Haematological Effects of COVID-19 Infection.

Authors:  T M Wiggill; E S Mayne; J L Vaughan; S Louw
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Microfluidic-based approaches for COVID-19 diagnosis.

Authors:  Hsuan-Yu Mu; Yu-Lun Lu; Tzu-Hung Hsiao; Jen-Huang Huang
Journal:  Biomicrofluidics       Date:  2020-12-08       Impact factor: 2.800

4.  Mitigating Risk of COVID-19 in Dialysis Facilities.

Authors:  Alan S Kliger; Jeffrey Silberzweig
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-20       Impact factor: 8.237

5.  Livestock plants and COVID-19 transmission.

Authors:  Charles A Taylor; Christopher Boulos; Douglas Almond
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-19       Impact factor: 11.205

6.  Outcomes and clinical practice in patients with COVID-19 admitted to the intensive care unit in Montréal, Canada: a descriptive analysis.

Authors:  Stephen Su Yang; Jed Lipes; Sandra Dial; Blair Schwartz; Denny Laporta; Evan Wong; Craig Baldry; Paul Warshawsky; Patricia McMillan; David Hornstein; Michel de Marchie; Dev Jayaraman
Journal:  CMAJ Open       Date:  2020-11-24

7.  Epidemiological and clinical characteristics of patients with suspected COVID-19 admitted in Metro Manila, Philippines.

Authors:  Eumelia P Salva; Jose Benito Villarama; Edmundo B Lopez; Ana Ria Sayo; Annavi Marie G Villanueva; Tansy Edwards; Su Myat Han; Shuichi Suzuki; Xerxes Seposo; Koya Ariyoshi; Chris Smith
Journal:  Trop Med Health       Date:  2020-06-22

8.  Sex Differences and COVID-19.

Authors:  Natalie Thomas; Caroline Gurvich; Jayashri Kulkarni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19.

Authors:  Benjamin Bowe; Miao Cai; Yan Xie; Andrew K Gibson; Geetha Maddukuri; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-16       Impact factor: 8.237

10.  Platelets and renal failure in the SARS-CoV-2 syndrome.

Authors:  Muhanad Taha; Dahlia Sano; Samer Hanoudi; Zahia Esber; Morvarid Elahi; Ali Gabali; Teena Chopra; Sorin Draghici; Lobelia Samavati
Journal:  Platelets       Date:  2020-09-06       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.